Woman who had child with brain damage and CP never had studies and testing done.
A Virginia woman, who delivered a child in 1997 with brain damage and later cerebral palsy, considered having another child in 2000. In discussing the risks of another pregnancy with a physician, she revealed she had lupus, migraine headaches, and supraventricular tachycardia that was treated with beta-blockers. She was told the risk of a brain hemorrhage like the one that caused her first child's damage could be reduced by regular monitoring for fetal growth, tracking of fetal movements, and FHR testing. When asked about the results from those tests in her first pregnancy, she informed them she had no such studies done. She said her physicians involved with the first delivery told her the child's problems were due to a placental abruption.
Once she learned this type of testing was standard of care for women with her medical conditions, she discovered further that a specialist had been consulted during her first pregnancy who did recommend testing, but these suggestions were not discussed with her nor were the tests performed.
The woman sued those involved with the first delivery and claimed that IUGR had occurred due to her lupus and the beta-blocker she took and that additional fetal monitoring was required when this was recognized. The child was born about a month early due to fetal distress and at age 9 had an IQ of 48 and functioned at the level of a child less than 3-years-old. A $28 million award was granted.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More